Public Supports Trump Drug Pricing Plan
A survey commissioned by the Pharmaceutical Reform Alliance and conducted by National Research Inc. finds that a majority of voters are in favor of lawmakers and candidates who they believe will take on Big Pharma price-gouging. Most say they support President Trump’s most-favored-nation drug pricing policy, where prices in the U.S. are set based on the lowest price in other developed nations.
#drugpricing #mfn #irp #trump
https://thehill.com/homenews/5343025-survey-voters-big-pharma-most-favored-nation
Will Senate Go After Medicare?
Despite discussing proposals to rein in Medicare Advantage (MA) overpayments in the budget reconciliation bill, some Republicans are saying there is little appetite to add such cuts in. This comes from senators who sought their inclusion.
In addition, the House has passed tweaks to the bill they adopted to ensure consistency with Senate Byrd reconciliation rules.
Additional article: https://www.politico.com/news/2025/06/10/house-gop-reveals-list-of-tweaks-to-megabill-00398669 and https://thehill.com/homenews/house/5345047-house-gops-technical-changes-trump-agenda-bill/?tbref=hp
#medicareadvantage #riskadjustment #overpayments #budgetreconciliation
https://thehill.com/homenews/senate/5344838-medicare-advantage-reform-less-likely
Reasons Beneficiaries Disenroll From Medicare Advantage
A study published in the June Health Affairs finds that Medicare Advantage (MA) members are most likely to disenroll from their MA plan due to four main reasons: difficulty accessing care, low plan generosity, dissatisfaction with care quality, and the type of plan (HMO vs. PPO). The study looked at data from the 2015 to 2020 Medicare Current Beneficiary Survey.
#medicareadvantage #marketing
https://www.beckerspayer.com/payer/4-reasons-why-members-leave-a-medicare-advantage-plan-study
— Marc S. Ryan
